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Whole-genome sequencing (WGS) of human genomic
DNA with next-generation sequencers (NGSs) has
opened a new avenue for personalized healthcare and
personalized medicine based on the detection of genetic
variations related to physical traits [1,2]. The application of
human WGS to large-population genetics requires rapid,
low cost, and accurate validation technologies.
The resequencing market is currently dominated by
Illumina HiSeq sequencing platforms (hereafter referred
to as HiSeq) that have been applied in large population
studies [3-5]. Bridging PCR amplification of fragmented
genomic DNA in a flow cell and sequencing-by-synthesis
chemical reactions truly realize massive parallel sequencing
from both ends of a DNA fragment [6]. The output from a
HiSeq instrument can reach up to 600 GB per run, with
more than 80% of the reads with an average quality score
higher than 30 (99.9% accurate). In particular, the
newly released protocol for HiSeq (PCR-free library
construction with rapid-run mode: 162 bp paired ends)
omits the initial PCR amplification step during library
construction and completes human WGS with high
depth (up to 33×: 100 GBs) in two days in one flow
cell. This improved protocol is expected to accelerate
the discovery of disease-susceptible variants by the
WGS analysis of human populations on a large scale.
Importantly, the accuracy of variant calls made with NGS
data is critical for future genetic investigations that aim to
detect disease-susceptible single nucleotide variations
(SNVs) [7]. Even with the improvements in the chemistry
used and in the equipment, systemic biases have been re-
ported for both the genome coverage and the accuracy of
variant calls of most NGSs [8]. Currently, the validation of
SNV calls that are newly discovered using NGSs depends
on conventional methods based on amplification of the tar-
get region with PCR, Sanger sequencing, hybridization of
sequence-specific oligonucleotide probes, and mass spec-
troscopic assays [4,8]. More than three million SNVs
have been reported in a human genome compared with
the reference GRCh37/hg19 sequence (http://www.ncbi.
nlm.nih.gov/projects/genome/assembly/grc/) [4]. In the
analyses of large populations, comprehensive validation
of newly observed SNVs is sometimes prohibitively
expensive and tedious using these traditional low-
throughput methods.
It is of interest to discover whether the overall accur-
acy of variant calls can be improved using a hybrid ap-
proach such as using NGSs with different working
principles to analyze the same genome, as indicated pre-
viously [4,8]. The rationale of this notion is that
platform-specific biases or errors in the data from one
NGS platform can be corrected by using the data from
another NGS platform, if the two methods are based on
different working principles. We surmised, therefore,that an appropriate combination of different NGSs may
reduce the overall cost of sequencing.
A semiconductor-based non-optical NGS has recently
become available [9]. These sequencers are attractive candi-
dates as alternatives to HiSeq. The semiconductor se-
quencers directly detect changes of pH that are caused by
the release of hydrogen ions when nucleotides are incorpo-
rated into the growing DNA strand during the DNA
polymerase reaction in cells within a chip, which is manu-
factured using the same technology that is used to con-
struct integrated circuits [9]. This method features rapid
reaction time and low price in consumables per base
[10,11]. The first semiconductor-based NGS, Ion Torrent
Personal Genome Machine, has been used widely in many
different applications [11-16]. The larger Ion Proton semi-
conductor NGS (hereafter referred to as Ion Proton) has
now been launched, and the total output of the Ion Proton
I chip is reported to be nearly 10 GB, which is suitable for
targeted resequencing of, for example, the human exome.
Because the sequencing reaction in semiconductor-based
NGSs does not use terminator nucleotides, the accuracy of
the generated reads are known to decrease for homopoly-
mer repeat sequences [10,12,17-20]. Nonetheless, many
known disease-causing mutations have been detected by
the semiconductor sequencers [11,12,14,15,21], implying
the potential of the platform.
It has been reported that a PCR-free protocol for HiSeq
is not free from coverage bias, especially for high and low
GC regions [17]. Therefore, the addition of exome data
(generated using low-cost NGSs) to the WGS data proc-
essed by HiSeq may strike a balance between cost and
benefit, making it an attractive strategy for sequencing
functionally important regions in human populations. Here,
we compare the variant call results for the genomic DNA
of 12 Japanese individuals generated by WGS on HiSeq
2500 in rapid-run mode and targeted exome sequences ob-
tained using on Proton with the I chip. We used the Omni
2.5-8 SNP arrays as references for the variant calls and
compared the SNP data among the three platforms. We
found that Ion Proton exhibited high concordance in vari-
ant calls with the other two platforms, indicating that Ion
Proton is a promising tool for validation of multiple SNPs
in the WGS of a large population.
Results
Outline of sequence outputs
A new sequencing protocol for HiSeq 2500, namely, a
rapid-run mode with 162 bp paired-end sequences, was
used in this study. A summary of the WGS data for the
samples from 12 Japanese individuals produced by HiSeq
2500 is shown in Table 1. The average total number of
bases and mapping ratio for the 12 samples were 101 GB
and 95.7%, respectively (Table 1). The percent coefficient
of variation (%CV) of total bases and mapping ratios
Table 1 Basic statistics of the whole genome sequences generated by the HiSeq sequencer
Samples Total bases (GB) Average depth Read 2 %Q30: 100–150 cycles Aligned bases (GB) Mapping ratio (%) SNPs
01 103 33.6 0.740 101 98 3,631,549
02 100 32.4 0.670 97.3 97 3,606,901
03 106 34.3 0.600 97.1 92 3,597,816
04 104 34.0 0.710 101 96 3,625,724
05 96 30.6 0.670 91.4 95 3,601,895
06 99 30.8 0.660 96.0 97 3,604,534
07 96 31.4 0.690 93.9 98 3,588,904
08 97 31.1 0.590 90.2 93 3,598,436
09 104 33.2 0.610 96.8 93 3,603,430
10 96 31.5 0.740 92.6 97 3,601,931
11 106 34.4 0.740 104 98 3,616,799
12 100 31.3 0.520 94.1 94 3,569,104
Mean 101 32.4 0.662 96.3 95.7 3603919
%CV 3.7 4.3 10 4.2 2.2 0.43
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http://www.biomedcentral.com/1471-2164/15/673among the 12 samples was small (Table 1), indicating that
the quality of the sequence reaction was comparable
among the samples. The automatic library construction
using the Agilent Bravo liquid-handling robot contributed
to the reproducibility among the samples. The %CV of
quality scores (Q30) of the 100 to 150 cycles of READ 2
was a bit higher (10%), implying that the sequencing-by-
synthesis technology may be less stable during the final
one sixth of the cycles.
A summary of the whole exome sequencing data for the
same 12 Japanese samples produced by Ion Proton isTable 2 Basic statistics of whole exome sequences generated
Samples Total bases (GB) Average depth Average read len
01_1 6.77 65.9 121
01_2 8.37 85.1 127
02 10.8 122 142
03_1 8.24 78.5 144
03_2 8.93 93.0 139
04 11.2 126 149
05 12.2 147 148
06 9.25 94.5 149
07 12.1 135 149
08 10.7 103 138
09 10.9 121 137
10 11.6 136 142
11 10.4 85.5 134
12 11.3 133 146
Mean 10.2 109 140
%CV 15 23 5.9
Two independent runs (indicated as _1 and 2) were performed for Samples 01 andshown in Table 2. Two samples (01 and 03) did not meet
our criteria for total number of bases (9 GB) with one Ion
Proton I chip experiment; therefore, we repeated the Ion
Proton run with samples from the same library and merged
the two results before the variant calling (Table 2 and
Methods). Although we used a 200 base read protocol, the
average read length that we obtained was 140 (Table 2) be-
cause Ion Proton automatically trims unreliable bases [18].
We found that the variance in average read length was
small compared with the variance in the total number of
bases (p = 1.0 × 10−17, Student’s t-test), indicating that theby the Ion Proton sequencer
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was reproducible. Consequently, the %CV of the aligned
bases was quite small (0.87%). The mean coverage depth of
target sequences was 109× (Table 2), while the coverage
depth may be somewhat overestimated because PCR dupli-
cation was not removed for the mapping. These results
demonstrate that the HiSeq sequencing and Ion Proton se-
quencing both attained the standard quality.
Comparison of SNP calls among three platforms
To assess the potential of the Ion Proton exome sequen-
cing to validate the SNV calls for the WGS generated by
HiSeq 2500 of the 12 Japanese population samples, we
evaluated the SNP calls using the Illumina Omni 2.5-8
SNP chip (hereafter referred to as Omni 2.5-8) as a ref-
erence to characterize the differences between the two
NGS platforms. The reported Japanese genomic se-
quence generated by HiSeq 2000 seemed to be sub-
stantially different from the GRCh37/hg19 reference
genome [22]. We focused on the autosomal target se-
quences of the Ion Proton exome kit (TargetSeq Ex-
ome Enrichment Kit, total target regions: 50 MB) to
compare the NGS results from the two platforms. We
extracted the variant call results, and tested the vari-
ants at the loci covered by Omni 2.5-8. A total of
79,143 SNPs on the autosomes in the 12 Japanese ge-
nomes were tested (Methods).
The numbers of called autosomal SNPs and the de-
grees of concordance among the three platforms (Omni
2.5-8, HiSeq, and Ion Proton) were the positivity of the
alternate alleles, regardless of its allelic state (homozy-
gous or heterozygous), from the GRCh37/hg19 referenceTable 3 Concordant SNP calls made from the HiSeq, Ion Proto
Samples Total calls Omni 2.5 HiSeq Proton All concordant
01 17031 16902 16782 15678 15549
02 17168 17007 16872 14033 13879
03 17156 17009 16860 15025 14855
04 16964 16847 16712 15668 15552
05 17029 16930 16782 16326 16208
06 17151 17033 16873 15863 15723
07 17193 17058 16918 16060 15905
08 17223 17099 16939 16095 15935
09 17282 17173 17017 16220 16084
10 17030 16922 16800 16180 16067
11 17086 16944 16802 14332 14182
12 17234 17100 16938 16163 15996
Average 17129 17002 16858 15637 15495
%CV 0.56 0.54 0.49 4.7 4.8
HO concordant, HiSeq 2500 and Omni 2.5-8 chip SNP calls were concordant but no
were concordant but not the Omni 2.5-8 chip calls. OP concordant, Omni 2.5-8 chip
Calculation of proton support = All concordant/HO concordant.genome. Omni 2.5-8 called 17,002 alternate alleles per
person, either homozygous or heterozygous, on the 12
Japanese sequences and the %CV of the total calls of in-
dividuals was 0.54% (Table 3). The average number of
SNPs called by the HiSeq software (16,858 SNPs) was
fairly similar to the number called from Omni 2.5-8 with
a similar variance (and 0.49%CV) (Table 3). Ion Proton
called 15,637 SNPs with a relatively large variance (4.7%
CV) among the 12 samples (Table 3). Therefore, we
concluded that Ion Proton made less stable SNP calls
among the individuals than HiSeq.
Concordance between the Omni 2.5-8 and HiSeq calls
was very high and much less variable among the samples
(98.8–99.0% concordance) than the concordance be-
tween the Omni 2.5-8 and Ion Proton calls (81.8–96.0%
concordance). The concordance among the calls by the
three platforms exhibited relatively high variance com-
pared with the concordance between the Omni 2.5-8
and HiSeq calls. The %CV is as low as 0.48% for the
concordance between the calls made by Omni 2.5-8 and
HiSeq. The variance in the numbers of concordant SNPs
among the 12 individual genomes seems to be caused by
fluctuations in the number of SNPs (14,033–16,220)
called by Ion Proton (Table 3).
Venn diagrams of the SNP calls shared among the
three platforms are shown in Figure 1. A maximum of
97% of the HiSeq calls for any one individual were sup-
ported by the Ion Proton calls (see also Table 3). Indeed,
the numbers of concordant SNPs including “negative”
calls (SNP calls that corresponded to reference genome
sequences) were nearly 98% (Figure 1 and Additional file
1: Table S1). The overall concordance of SNP calls maden, and Omni 2.5-8 SNP array data
HO concordant HP concordant OP concordant Proton support
16733 15576 15571 0.929
16820 13896 13907 0.825
16806 14889 14898 0.884
16663 15580 15572 0.933
16732 16238 16247 0.969
16832 15744 15765 0.934
16862 15939 15947 0.943
16892 15965 15988 0.943
16965 16114 16133 0.948
16747 16098 16094 0.959
16768 14199 14207 0.846
16889 16028 16046 0.947
16809 15522 15531 0.922
0.49 4.8 4.8 4.7
t the Ion Proton calls. HP concordant, HiSeq 2500 and Ion Proton SNP calls
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Figure 1 Venn diagram of SNP calls for each sample shared among the three platforms. The numbers in each area indicate the number of
SNPs. The size of the area is not proportional.
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was 99.6% and 97.5%, respectively (Additional file 1:
Table S1). These numbers are comparable with similar
results reported in a previous study [10]. While almost
200 of the called SNPs were discordant between Omni
2.5-8 and both HiSeq and Ion Proton (Additional file 1:
Table S1), many of these SNP calls seemed to be derived
from a difference in the allelic calls in the manifest file
of Omni 2.5-8 [10]. These results support the promising
potential of combining the NGS platforms as a multiple
validation method for SNV calls in population studies.
Reproducibility of SNP calls by individual NGSs
To analyze the reproducibility of SNP calls among the
three platforms in detail, a level plot of the numbers of
alternative allele calls in the 24 alleles (12 individual
samples with two possible alleles for each SNP) was
generated (Figure 2). If all the SNP calls are completely
identical between two of the three platforms, the data
points accumulate on the 1:1 diagonal line. For theHiSeq and Omni 2.5-8 SNP calls, the points accumu-
lated along the diagonal line, indicating very high con-
cordance between these two platforms (Figure 2A). For
both the HiSeq and Omni 2.5-8 SNP calls against the
Ion Proton calls, the plot showed that Ion Proton tended
to call a lower number of SNPs than HiSeq and Omni
2.5-8 (Figure 2B and 2C). However, we also found that
only a small fraction of alternate alleles in the 12
Japanese samples at one of the SNP loci was never called
by Ion Proton (horizontal axes of Figure 2B and 2C).
The level plot analysis also indicated possible systemic
errors inherent in each platform. For example, 53 SNPs
were not called by HiSeq for any of the 12 samples,
whereas all of them were called as homozygous for the
alternate alleles by Omni 2.5-8 (Figure 2A, upper left
corner). Visual inspection of the BAM files using the
Integrated Genome Viewer [23,24] suggested that some
of the SNP loci may be caused by the large structural
variations that are commonly found in the genomes of


















































Figure 2 Level plots of alternative allele counts among the three platforms. Scatter plots of alternative allele counts between A) HiSeq
and Omni 2.5-8, B) HiSeq and Proton, and C) Proton and Omni 2.5-8 are indicated. The vertical and horizontal axes show the numbers of
alternative allele calls for each platform. The color bar indicates the number of SNPs in a pixel. There were 12 individual samples, so the
maximum number of alternative alleles is 24. The digits with arrows near the corner indicate the numbers of SNPs at the corner pixels.
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mapping of NGS reads to reference genomes.
To detect systemic errors in the SNV calls, we ana-
lyzed the commonly discordant SNPs among the 12
individuals (Table 4). On average, Ion Proton called
1,849 SNPs that exhibited discordant variant calls in an
individual exome, and 43 (2.3%) of them were com-
monly discordant among the 12 Japanese genomes.
HiSeq called an average of 64 SNPs that were discord-
ant with Ion Proton and Omni 2.5-8, suggesting that
Ion Proton may cover some calls that were missed by
HiSeq. Together, these results indicate that the two
NGS platforms showed no strong systemic calling
biases for the SNPs covered by Omni 2.5-8.
Effects of sequence depth and GC contents on SNP calls
by the NGSs
Read depth, GC content, and homopolymer stretches
have been identified as critical factors for the accuracy
of SNV calls made by the NGSs [17,20,25]. For HiSeq,
the read depth at each SNP was significantly different
between the concordant and discordant calls with Omni
2.5-8 (p < 0.001, Mann–Whitney U test) as well as with











Average 64 1849 76945
%CV 19.6 55.6 1.24
Common 1 43 66472Similarly, the variant calls discordant with Ion Proton
exhibit significantly lower read depth (p < 0.001, Mann–
Whitney U test, Figure 3B). These results confirm the pre-
vious observations that read depth can be a major factor in
determining the quality of variant calls. As mentioned
earlier, we did not eliminate duplicate reads from the
Ion Proton data. The ratio of duplicated reads at SNVs
in the Ion Proton reads for each of the 12 samples was
found to be inversely correlated to the concordance
of SNP calling comparing with the Omni 2.5-8 (Additional
file 2: Figure S1).
The GC content was calculated in a 101-base window
for each SNP locus (50 bases on each side). We found
that Ion Proton calls were affected in the loci with
higher GC content (Figure 4). For the HiSeq SNP calls,
no significant difference in the GC content of the loci
was detected between the SNPs concordant and discordant
with Omni 2.5-8, whereas, for the Ion Proton calls, some
significant difference was found (p < 0.01, Figure 4A). Simi-
larly, the concordant SNPs between Ion Proton and Omni
2.5-8 tended to have higher GC content than the discord-
ant SNPs (Figure 4B). These results indicate that GC con-
tent in the SNP loci affected the quality of SNP calls by the
NGSs, especially for Ion Proton.nt or discordant with Omni 2.5-8
ant
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Figure 3 Box plots of read depths at concordant/discordant SNP loci among the NGSs and Omni 2.5-8. A) Box plots of the NGS read
depth at the SNP loci showing concordance/discordance between the NGSs and Omni 2.5-8. The box indicates the first and third quartiles and
the lines indicate the highest and lowest value that is within 1.5 x inter-quartile range. Outliers were omitted. The graph on the left indicates the
distribution of read depths at HiSeq2500 SNP loci and the graph on the right indicates the distribution of read depths at Ion Proton and Omni
2.5-8 SNP loci. B) Box plots of the NGS read depths at the SNP loci showing concordance/discordance among the three platforms. The box indicates the
first and third quartiles and the lines indicate the highest and lowest value that is within 1.5 x inter-quartile range. Outliers were omitted. The three columns
(shaded gray rectangle) from right indicate the distribution of read depths of the discordant SNPs between the NGSs and Omni 2.5-8. The read depth at
SNP loci that showed Ion Proton discordance against HiSeq 2500 and Omni 2.5-8 was significantly different. The read depths at SNP loci for SNPs that both
HiSeq 2500 and Ion Proton failed to call are shown in the gray box.
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quencers frequently show insertion/deletion (indel) errors
at loci with homopolymer sequences [17-19]. However,
against our expectation, homopolymer length in the SNP
loci did not affect the number of discordant SNPs between
Ion Proton and Omni 2.5-8 (Figure 5), suggesting that
SNPs in short homopolymer stretches can be detected by
Ion Proton.
Logistic regression analyses indicated that read depth
was the strongest factor for discordant calls against
Omni 2.5-8 for both HiSeq and Ion Proton (Table 5);
however, GC content affected more Ion Proton calls (2.5
fold) than HiSeq calls. In contrast to the effect of homo-
polymer sequences on discordant SNP calls, the logistic
regression analysis results showed that homopolymer se-
quences in the SNP loci effected Ion Proton variant calls
more strongly than they affected HiSeq variant calls,
even though the overall effects were not significant
(Table 5 and Figure 5). These results indicate that allthree factors (read depth, GC content, and homopoly-
mer stretches) may affect the accuracy of the Ion Proton
SNP calls, whereas read depth may be the major factor
for the accuracy of the HiSeq SNP calls.
In addition, we calculated the transition/transversion
ratio for Omni 2.5-8 and the two NGSs and found that
the transition/transversion ratio was smaller for vari-
ant calls between the two NGSs but not between either
of the two NGSs and Omni 2.5-8 or are all discordant
SNPs, indicating that the NGSs might miss more tran-
sitions than transversions (Additional file 1: Table S2).
The transition/transversion ratio values that we ob-
tained are compatible to the ratios reported in a previ-
ous study [26].
Discussion
In this paper, variant SNP calls in the exonic sequences
from the genomic DNA of 12 Japanese individuals were





































































































Figure 4 Box plots of GC content at concordant/discordant SNP loci among the NGSs and Omni 2.5-8. A) Box plots of the GC content at
the SNP loci showing concordance/discordance between the NGSs and Omni 2.5-8. The box indicates the first and third quartiles and the lines
indicate the highest and lowest value that is within 1.5 x inter-quartile range. The graph on the left indicates the distribution of GC content at
HiSeq SNP loci. There was no statistically significance difference in GC content between the concordant and discordant SNPs (p = 0.81). The graph
on the right indicates the distribution of GC content at Ion Proton and Omni 2.5-8 SNP loci. The difference in GC content between concordant and dis-
cordant SNPs was significant (p = 2.2 × 10−16). B) Box plots of the GC content at the SNP loci showing concordance/discordance among the three plat-
forms. The three columns (shaded gray rectangle) from right indicate the distribution of GC content of the discordant SNPs between the NGSs and Omni
2.5-8. The GC content at SNP loci that showed Ion Proton discordance compared with HiSeq and Omni 2.5-8 was significantly different (p = 0.026).
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2500, and Omni 2.5-8. The Omni 2.5-8 chip SNP calls
were used as the reference. Approximately 80,000 SNP
loci were analyzed in this study from which Omni 2.5-8
called 17,000 variants, and more than 90% of these vari-
ant calls were supported by both HiSeq and Ion Proton.
Ion Proton exhibited a maximum of 96% concordance of
SNP calls with the SNP calls by the other two platforms,
indicating that Ion Proton is a promising tool for the valia-
dation of multiple SNPs. Nonetheless, improvements in the
sensitivity of Ion Proton for alternative alleles are still ne-
cessary for the efficient detection of novel SNVs in a human
genome using Ion Proton.
Of the three factors that are known to affect SNV call-
ing by NGSs, we found that all three factors (read depth,
GC content, and homopolymer length) affect more or
less the accuracy of Ion Proton SNP calls, whereas readdepth was the major factor that affected HiSeq SNP
calls. GC content has been shown to be a confounding
factor for exon capturing [27-29]; therefore, the accuracy
of Ion Proton SNP calls may have been affected by dif-
ferences in the GC content near the SNP loci. Non-
optical semiconductor-based sequencers like Ion Proton
have been used widely for multiple amplicon sequencing
[11-13,30-35]; however, it has been reported that these
sequencers exhibit relatively high error rates, especially
for homopolymer sequences [17-19,36]. While homopol-
ymer length did affect the accuracy of the Ion Proton
SNP calls more than it affected the accuracy of the
HiSeq SNP calls, its affect on the Ion Proton SNP calls
was small (the logistic regression coefficient for homo-
polymer length in Ion Proton was 0.0123, Table 5).
An interesting question is whether Ion Proton can cover











































Figure 5 Distribution of homopolymer lengths at concordant/discordant SNP loci among the three platforms. The vertical axis of each
panel indicates the density of each homopolymer at the SNP loci, calculating the total number of SNPs for each category as 1. The horizontal axis
of each panel indicates the length of the homopolymers.
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http://www.biomedcentral.com/1471-2164/15/673call from 22 to 53 SNP calls in the 12 individual samples,
which were called commonly by Ion Proton and Omni 2.5-
8 (Figure 1), indicating that Ion Proton may cover the
HiSeq missed calls. The Ion Personal Genome Machine
(PGM) that preceded Ion Proton was used for a similarTable 5 Logistic regression analysis among QC factors of NGS
Platform A B C
Read depth GC contents Ho
HiSeq 2500 0.0854 0.0021 0.0
Ion Proton 0.0759 0.0051 0.0purpose in the characterization of the Tasmania devil gen-
ome sequence [37].
We found that there was a significant difference be-
tween the number of SNPs called among the 12 samples
by HiSeq and Ion Proton, and the variance was largerand calling discordance with Omni 2.5-8
A + B A + C A + B + C
mopolymer
00074 0.0896 0.104 0.106
123 0.0837 0.0759 0.0839
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sequencing processes in Ion Proton after the chip
loading appeared to exhibit reproducibility similar to
that of HiSeq during sequencing-by-synthesis. There-
fore, the major reason for the variance in the number
of Ion Proton SNP calls must be in the different li-
brary construction procedures that are used in the
two NGSs. In this study, the library preparation pro-
cedures that we used for Ion Proton were manual,
whereas liquid-handling robots were used for the con-
struction of libraries for HiSeq. We surmise that the
Ion Proton output will improve if automated liquid-
handling procedures can be established. Indeed, we
found that the reproducibility of library construction
for Ion Proton was improved using an automated li-
brary construction method (SS, INM, and JYa: unpub-
lished observation).
We found that most of the SNPs called by HiSeq
were supported by the Ion Proton SNP calls; indicat-
ing that Ion Proton could be used to validate novel
SNPs in a population. However, if the SNPs are rela-
tively rare in a population, they may not be validated
by Ion Proton. In fact, the pixels near the origin on
the horizontal axis are a bit brighter than those far-
ther from the origin, as can be seen in Figure 2B and
2C. The data plotted in Figure 2B and 2C demon-
strated how the addition of Ion Proton SNP call data
to HiSeq SNP calls can provide strong support for
the identification of alternate alleles in a population
of interest. Our results suggest that approximately
97% of the expected SNVs in exonic regions of a hu-
man genome will be verified by Ion Proton exome se-
quencing. This finding will contribute to designing
custom arrays for large-scale population-specific gen-
etic studies of populations of unique origin, like the
Japanese.
Conclusions
Validation of SNVs detected in WGS is critical for
studying disease-related variations in human popula-
tion genetics. Combining different types of NGSs in
analyses of the genome sequences from the same
individual may be an efficient means of validateing mul-
tiple SNV calls simultaneously. Here, we attempted to
show the versatility and usefulness of the combination
of Ion Proton exome sequencing with HiSeq 2500
WGS by analyzing 12 independent Japanese genomes
sequences and comparing the corresponding SNP calls,
with the Omni 2.5-8 SNP calls as the reference. We
found that Ion Proton exhibited a maximum of 97%
concordance in variant calls with the other two plat-
forms, indicating that Ion Proton is a promising tool
for the validation of multiple SNPs in the exons of gen-
omic sequences.Methods
Specimens
The Tohoku Medical Megabank Organization (Tohoku
University Graduate School of Medicine, Miyagi, Japan)
constituted the prospective cohort (design paper is in
preparation), and 5 ml of peripheral blood was donated
by the Japanese participants, all with written informed
consent. The whole project was approved by the ethical
committee of the Tohoku University School of Medicine.
Because of their availability for further follow-up investi-
gations, we selected the first 12 participants of the co-
hort (10 males and 2 females) who lived in the neighbor
of Tohoku Medical Megabank Organization.
DNA preparation
To extract the genomic DNA, the whole peripheral
blood samples were processed with an Autopure LS sys-
tem (Qiagen, Germany) for automated nucleotide purifi-
cation following the manufacturer’s instructions. We
omitted the RNase treatment, measured the concentra-
tion of the double-stranded DNA with PicoGreen (Life
Technologies, Carlsbad, CA), and adjusted the concen-
tration of the DNA to 200 ng/μL in Elution Buffer
(Qiagen, Germany).
PCR-free whole-genome sequencing with the HiSeq 2500
sequencer
The genomic DNA (2 μg in 100 μL) was sonicated using
a Covaris LE220 (Covaris Inc., Woburn, MA) to an aver-
age target size of 550 bp. The sheared DNA was used
for library construction with the TruSeq DNA PCR-free
sample preparation kit (Illumina, San Diego, CA) on a
Bravo liquid-handling instrument (Agilent Technologies,
Santa Clara, CA). The libraries were analyzed using a DNA
Fragment Analyzer (Advanced Analytical Technologies,
Ames, IA) and quantified by real-time PCR using the
KAPA Library Quant Kit (KAPA Biosystems, MA).
Ten microliters of 2 nM libraries were denatured with
an equal volume of 0.1 N sodium hydroxide; 1.5–2.0 pM
of the denatured library was then used for on-board
cluster generation on a HiSeq 2500 system (Illumina)
with a TruSeq Rapid PE Cluster Kit (Illumina). Then the
sequencing-by-synthesis reaction was performed in rapid-
run mode with a 162-bp paired-end protocol. We ran one
sample per flow cell so that no index read was needed. For
each reaction, one and a half TruSeq Rapid SBS (sequen-
cing-by-synthesis) kits (200 cycle) were used.
Preparation of libraries for TargetSeq exome capture
Genomic DNA was prepared for exome capture according
to the protocol included with the Ion Xpress Plus Fragment
Library Kit for the AB Library Builder (Life Technologies,
Carlsbad, CA) using the AB Library Builder System (Ap-
plied Biosystems, Foster City, CA). The DNA solvent was
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zymatic shearing was performed using 1–2 μg genomic
DNA per sample. Sheared DNA was purified using the
Agencourt AMPure XP Reagent (Agencourt, Boston, MA)
with a target size peak of 350 bp, followed by adaptor
ligation (A1 and P1). The adaptor-ligated genomic DNA
fragments were then eluted in 45 μL of low TE buffer and
amplified by PCR using 200 μL of Platinum PCR Supermix
High Fidelity (Life Technologies), 5 μL of 50 μM library
amplification primer mix, and 45 μL ligated DNA. The
thermal cycling protocol was initial denaturation at 95°C
for 5 min, followed by 7–8 cycles at 95°C for 15 s, 58°C for
15 s, and 72°C for 60 s. The amplified library was purified
and eluted in 50 μL of low TE buffer using AMPure XP
reagent.
Exome capture
Pre-capture library DNA was hybridized to exome cap-
ture probes using an Ion TargetSeq Exome Enrichment
Kit (Life Technologies) according to the manufacturer’s
specifications. A total of 500 ng of library DNA, 5 μL of
1 mg/mL Human Cot-1 DNA, and 5 μL of Ion Target-
Seq Blocker P1 and A per sample were mixed and dried
using a CC-105 centrifugal concentrator (TOMY, Tokyo,
Japan) at the high temperature setting for 40 min. The
dried DNA was dissolved in 7.5 μL of TargetSeq
Hybridization Solution A, added to 3 μL of Enhancer B
and 4.5 μL of Exome Probe Pool, and hybridized at 47°C
for 72 hours in a Veriti Thermal Cycler (Applied Biosys-
tems, Foster City, CA). The probe-hybridized library
DNA was enriched by binding to streptavidin-coated M-
270 beads (Dynal, Oslo, Norway), rotated at 650 rpm at
47°C for 45 min in a Thermomixer comfort (Eppendorf,
Hamburg, Germany). The streptavidin conjugate was
washed with TargetSeq Hybridization and Wash Kit so-
lutions (Life Technologies) strictly according to the man-
ufacture’s protocol and eluted in 30 μL of DNase-free
water. The probe-hybridized DNA was further amplified
by PCR using 200 μL of Platinum PCR Supermix High
Fidelity, 20 μL of library amplification primer mix, and
30 μL of the probe-hybridized DNA. The thermal cyc-
ling protocol was initial denaturation at 95°C for 5 min
followed by 12 cycles at 95°C for 15 s, 58°C for 15 s, and
72°C for 60 s. The amplified exome DNA library was
subjected to size selection using E-Gel SizeSelect Agar-
ose Gel (Applied Biosystems), purified twice with a 1.5-
fold volume of AMPure XP reagent, and eluted in 25 μL
of low TE buffer. The quantity and quality of the cap-
tured libraries were assessed using a StepOne Plus qPCR
instrument (Life Technologies) with an Ion Library
Quantitation Kit (Life Technologies) and Bioanalyzer in-
strument (Agilent Technologies, Santa Clara, CA) with
Agilent High Sensitivity DNA Kit (Agilent Technologies)
according to the manufacturers’ instructions.Template preparation and sequencing with an Ion Proton
sequencer
Emulsion PCR was performed using a OneTouch 2 in-
strument (Life Technologies) with an Ion PI Template
OT2 200 Kit v2 following the manufacturer’s instruc-
tions. The enrichment of template-positive Ion Sphere
Particles (ISP) in the Ion Proton I chip was achieved
using the Ion OneTouch ES enrichment system (Life
Technologies). Ion Proton I chip version 2 was prepared
and loaded according to the manufacturer’s recommen-
dations. The total base output as a criterion for a suc-
cessful experiment was set as 9 GB. If a sample did not
reach this criterion for the total base output in one ex-
periment, we performed the sequencing again with the
same library and merged the results before aligning the
reads to the reference GRCh37/hg19 sequence.
SNP array scanning with the iScan system
We used a Human Omni 2.5-8 v1.1 DNA Analysis Kit
(Illumina) to analyze 160 ng of genomic DNA following
the manufacturer’s instructions. In brief, the genomic
DNA was subjected to isothermal amplification followed
by fragmentation with nuclease. The DNA was precipitated
with 2-propanol, then hybridized with oligonucleotide
probes immobilized on Human Omni 2.5-8 BeadChips
(eight samples per BeadChip slide). After washing, the
probes underwent single-base extension using the captured
genomic DNA as templates and incorporating 2, 4-
dinitrophenyl- or biotin-labeled nucleotides to identify the
genotypes. Then, immunohistochemical staining was per-
formed to amplify the incorporated signal. Two Robotic
Universal modules (Freedom evo, TECAN, Maennedorf,
Switzerland) and the Illumina Infinium LIMS system (Illu-
mina) were used in a series of experiments. An iScan
scanner system with AutoLoader 2.X controlled by iScan
Control Software ver. 3.3.28 (Illumina) was used for data
acquisition. The SNP calling was performed using the
Genotyping Module in the GenomeStudio software
(ver.2011.1: Illumina). The default set cluster file was
HumanOmni2-5 M-8b1-1_B.egt (Illumina), and a Gen
Call Threshold of 0.15 was used for SNP calling. The
SNP call rate was calculated and samples with overall
call rates over 99% and LogRdev values below 0.2 were
used for further analysis.
Variant calling pipeline for Illumina HiSeq sequencing
Fastq files were generated by base calling with CASVA
1.8.2. Reads in the generated fastq files were mapped to
the human reference genome (GRCh37/hg19) with
decoy sequences (hs37d5) using the BWA-MEM align-
ment algorithm in BWA version 0.7.5a-r405 [38,39] with
the default options, and stored as BAM files. The follow-
ing post-processing was applied to the BAM files: reads
in the BAM files were realigned with Realigner Target
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2.5-2 (GATK), and their base quality scores were recali-
brated with Base Recalibrator and Print Reads in GATK
[40,41]. For the Realigner Target Creator and Indel Rea-
ligner, no VCF file of known indel sites was given as input.
SNP sites in NCBI’s SNP database (dbSNP, version 137) in
a VCF file were input to Base Recalibrator as known
SNP sites. Variant calling was conducted with the
post-processed BAM files using Unified Genotyper in
GATK with the default options [40,41], and the results
were stored in VCF files.
Variant calling pipeline for Ion Proton sequencing
The variant calling pipeline of Life Technologies was
used to analyze the Ion Proton sequencing runs. Reads
were aligned to the GRCh37/hg19 reference sequence
using tmap software version 3.6.39. Variant discovery
and genotype calling of multi-allelic substitutions and
indels was performed on each individual sample using
the Torrent Variant Caller (TVC) version 3.6.39. Parame-
ters for variant discovery were set based on the “TVC 3.6
Parameters for TargetSeq Exome on Proton PI” with
thresholds (snp_beta_bias = 150, snp_strand_bias = 0.9999,
maximum common signal shift = 0.5, snp_min_variant_
score = 5, and minimum_mapping _quality_score = 0)
changed from the default values suggested by Life Tech-
nologies to use as many reads as possible.
Analysis tools and selection of SNPs
To compare the genotypes from the three platforms, the
output VCF files from the two NGS outputs and the
Omni 2.5-8 output files formatted with PLINK [42] were
processed to generate subsets that contained the com-
mon target SNP sites. The common target SNP sites was
obtained by intersecting autosomal target manifests, Ion-
TargetSeq-Exome-50 Mb-hg19.bed by Life Technologies,
and the bed file of Omni 2.5-8 from the Human Omni 2.5-
8 v1.1 DNA Analysis Kit by Illumina, using the BEDTools
software suite [43].
SNPs outside of the common target SNP sites were fil-
tered out leaving 83,237 sites as the common targets.
From these loci, six probes for detection of copy number
variations were removed. We also found 2,626 overlap-
ping probes in the Omni 2.5-8 array and integrated the
SNP calls using these corresponding probes. In total, we
analyzed 79,143 SNPs.
Genotyping data on each platform were obtained from
the VCF files and PLINK/PED files using a set of in-
house scripts; then, the genotype concordance and ac-
curacy were calculated.
Statistical analyses
Differences in the NGS read depth between discordant
and concordant SNP calls with the Omni 2.5-8 callswere examined using the Mann–Whitney U test with
SAMtools [44], in-house scripts, and the R statistical
environment [45]. Logistic regression analyses for the dis-
cordant and concordant calls between the NGSs and Omni
2.5-8 with three NGS quality control (QC) parameters
(read depth, GC content, and homopolymer length) were
performed in the R statistical environment. Logistic regres-
sion analysis of the SNPs with read depths in the range of
± 1 SD from the average was performed.
Data availability
The SNP calls at each position covered by Omni 2.5-8
are attached as Additional file 3 (for HiSeq 2500),
Additional file 4 (for Proton), and Additional file 5 (for
Omni 2.5-8). Genomic DNAs used in this study will
be distributed through Tohoku Medical Megabank
Organization upon request.
Additional files
Additional file 1: Concordant/discordant SNPs and transition/
transversion ratios for Omni 2.5-8 and the two NGSs. This file
contains Tables S1 and S2 as Excel Spreadsheets.
Additional file 2: Effect of duplicated reads in the Ion Proton SNP
calls. This file contains Figure S1 in PDF format. The duplication rate of
Ion Proton reads was calculated for each sample using the
BamDuplicates module of the Torrent Suite 4.0 (Life Technologies). The
vertical axis indicates the mean duplication rate and the horizontal axis
indicates the concordance rate of variant calls between Omni 2.5-8 and
Ion Proton for each sample.
Additional file 3: The VCF file of merged SNP calls by HiSeq2500.
Additional file 4: The VCF file of merged SNP calls by Ion Proton.
Additional file 5: The VCF file of merged SNP calls by Omni 2.5-8.
These files contain SNP information corresponds to the Omni 2.5-8 probe
set found in the target exons of Ion TargetSeq Exome Enrichment Kit.
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